Generic drug maker Hi-Tech Pharmacal said that it has acquired marketing and distribution rights to pain treatments made by Atley Pharmaceuticals.

Eli Lilly will invest funds into its existing biotechnology capabilities to further research and development of multispecific therapeutics.

An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.

A new multimedia public service campaign that is designed to help families prevent food poisoning in the home has made its debut.

New data from a late-stage clinical trial of a recently approved drug for Type 2 diabetes show improved blood-sugar control in adults who take it with metformin or alone.

Looming gas prices are taking a toll on consumers' shopping habits, according to a special report by SymphonyIRI Group.

Abbott Diabetes Care reported Friday that a shipment of blood-glucose monitoring products was reported stolen from a shipping carrier facility in Louisville, Ky., on June 19.

Natural food company Bear Naked is giving consumers a boost with a new breakfast cereal.

Do or Die Fitness has introduced a new line of fitness tools designed to help people with knee, wrist and neck problems modify workout moves.

The Food and Drug Administration has accepted a regulatory approval application for a drug designed to prevent premature birth in pregnant women.

There’s a tremendous upside for retailers and suppliers, but that upside will come from doing things differently than in years past, as well as grappling with fragmentation. Those were a few of the key messages Bryan Gildenberg, chief knowledge officer of Kantar Retail, had for attendees of Monday morning’s business session at NACDS Marketplace in Boston.

Ingles Markets' board of directors declared a cash dividend of 16.5 cents per share on all of its Class A common stock and 15 cents per share on all of its Class B common stock.